Neurological Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Perspectives and New Development.

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of multiple malignancies, especially in non-small cell lung cancer (NSCLC). With the extensive application of ICIs in clinical practice, clinicians have to manage their toxicities, which are often termed immune-related adverse eve...

Full description

Bibliographic Details

Published in:	Clinical Medicine Insights: Oncology pp. 1 - 17
Main Authors:	Cheng, Ke, Wang, Yuqing, Zhou, Yuwen, Xia, Ruolan, Tang, Liansha, Liu, Jiyan
Format:	algorithm review tables/charts Journal Article
Published:	Sage Publications Inc. 11/24/2021
Online Access:	View this record in EBSCOhost